To investigate regulation mechanisms of LRIG3 and sLRIG3 relating to the malignancy of glioma cells, western blot analysis was performed to evaluate expression and activation levels of PDGFRα, EGFR, MET, Akt, and mTOR. The gene discussed is MET; the disease is central nervous system cancer.